CN112779262B - Application of pig RagC gene - Google Patents
Application of pig RagC gene Download PDFInfo
- Publication number
- CN112779262B CN112779262B CN202110034472.9A CN202110034472A CN112779262B CN 112779262 B CN112779262 B CN 112779262B CN 202110034472 A CN202110034472 A CN 202110034472A CN 112779262 B CN112779262 B CN 112779262B
- Authority
- CN
- China
- Prior art keywords
- ragc
- pig
- gene
- skeletal muscle
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101710094757 Ras-related GTP-binding protein C Proteins 0.000 title claims abstract description 133
- 230000002018 overexpression Effects 0.000 claims abstract description 37
- 210000000419 skeletal muscle satellite cell Anatomy 0.000 claims abstract description 36
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 35
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 27
- 238000001243 protein synthesis Methods 0.000 claims abstract description 15
- 230000014616 translation Effects 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 13
- 210000004027 cell Anatomy 0.000 claims description 43
- 239000013598 vector Substances 0.000 claims description 14
- 238000012408 PCR amplification Methods 0.000 claims description 11
- 241000713666 Lentivirus Species 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 210000004102 animal cell Anatomy 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 3
- 230000037257 muscle growth Effects 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000008135 Mechanistic Target of Rapamycin Complex 1 Human genes 0.000 abstract description 31
- 108010035196 Mechanistic Target of Rapamycin Complex 1 Proteins 0.000 abstract description 31
- 230000014509 gene expression Effects 0.000 abstract description 22
- 150000001413 amino acids Chemical class 0.000 abstract description 19
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 11
- 239000004472 Lysine Substances 0.000 abstract description 11
- 230000006698 induction Effects 0.000 abstract description 6
- 230000008859 change Effects 0.000 abstract description 5
- 230000012010 growth Effects 0.000 abstract description 5
- 210000003701 histiocyte Anatomy 0.000 abstract description 5
- 108091006146 Channels Proteins 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000013461 design Methods 0.000 abstract description 4
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 101000686231 Homo sapiens Ras-related GTP-binding protein C Proteins 0.000 abstract description 3
- 101000686230 Mus musculus Ras-related GTP-binding protein C Proteins 0.000 abstract description 3
- 102000034573 Channels Human genes 0.000 abstract description 2
- 102100025009 Ras-related GTP-binding protein C Human genes 0.000 description 44
- 239000013612 plasmid Substances 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 18
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 18
- 235000018102 proteins Nutrition 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 15
- 230000019491 signal transduction Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000001976 enzyme digestion Methods 0.000 description 9
- 230000029087 digestion Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 7
- 230000004913 activation Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 101710094755 Ras-related GTP-binding protein A Proteins 0.000 description 5
- 241000282887 Suidae Species 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 229930195712 glutamate Natural products 0.000 description 4
- 235000003642 hunger Nutrition 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 230000037351 starvation Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 102100025001 Ras-related GTP-binding protein A Human genes 0.000 description 3
- 101710094756 Ras-related GTP-binding protein D Proteins 0.000 description 3
- 102100025002 Ras-related GTP-binding protein D Human genes 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229950010131 puromycin Drugs 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 2
- 108091006109 GTPases Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010079364 N-glycylalanine Proteins 0.000 description 2
- 102100025006 Ras-related GTP-binding protein B Human genes 0.000 description 2
- 101710094754 Ras-related GTP-binding protein B Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000003208 gene overexpression Methods 0.000 description 2
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 230000007781 signaling event Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- GFBLJMHGHAXGNY-ZLUOBGJFSA-N Ala-Asn-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GFBLJMHGHAXGNY-ZLUOBGJFSA-N 0.000 description 1
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 1
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 1
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- NMXKFWOEASXOGB-QSFUFRPTSA-N Ala-Ile-His Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NMXKFWOEASXOGB-QSFUFRPTSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 1
- XAXMJQUMRJAFCH-CQDKDKBSSA-N Ala-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 XAXMJQUMRJAFCH-CQDKDKBSSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- UISQLSIBJKEJSS-GUBZILKMSA-N Arg-Arg-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(O)=O UISQLSIBJKEJSS-GUBZILKMSA-N 0.000 description 1
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 1
- KRQSPVKUISQQFS-FJXKBIBVSA-N Arg-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N KRQSPVKUISQQFS-FJXKBIBVSA-N 0.000 description 1
- AUIJUTGLPVHIRT-FXQIFTODSA-N Arg-Ser-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)CN=C(N)N AUIJUTGLPVHIRT-FXQIFTODSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CMLGVVWQQHUXOZ-GHCJXIJMSA-N Asn-Ala-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CMLGVVWQQHUXOZ-GHCJXIJMSA-N 0.000 description 1
- VKCOHFFSTKCXEQ-OLHMAJIHSA-N Asn-Asn-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VKCOHFFSTKCXEQ-OLHMAJIHSA-N 0.000 description 1
- JWKDQOORUCYUIW-ZPFDUUQYSA-N Asn-Lys-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JWKDQOORUCYUIW-ZPFDUUQYSA-N 0.000 description 1
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 1
- SNYCNNPOFYBCEK-ZLUOBGJFSA-N Asn-Ser-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O SNYCNNPOFYBCEK-ZLUOBGJFSA-N 0.000 description 1
- VTYQAQFKMQTKQD-ACZMJKKPSA-N Asp-Ala-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O VTYQAQFKMQTKQD-ACZMJKKPSA-N 0.000 description 1
- VZNOVQKGJQJOCS-SRVKXCTJSA-N Asp-Asp-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VZNOVQKGJQJOCS-SRVKXCTJSA-N 0.000 description 1
- ODNWIBOCFGMRTP-SRVKXCTJSA-N Asp-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CN=CN1 ODNWIBOCFGMRTP-SRVKXCTJSA-N 0.000 description 1
- KLYPOCBLKMPBIQ-GHCJXIJMSA-N Asp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N KLYPOCBLKMPBIQ-GHCJXIJMSA-N 0.000 description 1
- VSMYBNPOHYAXSD-GUBZILKMSA-N Asp-Lys-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O VSMYBNPOHYAXSD-GUBZILKMSA-N 0.000 description 1
- VMVUDJUXJKDGNR-FXQIFTODSA-N Asp-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N VMVUDJUXJKDGNR-FXQIFTODSA-N 0.000 description 1
- UCHSVZYJKJLPHF-BZSNNMDCSA-N Asp-Phe-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O UCHSVZYJKJLPHF-BZSNNMDCSA-N 0.000 description 1
- PWAIZUBWHRHYKS-MELADBBJSA-N Asp-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)O)N)C(=O)O PWAIZUBWHRHYKS-MELADBBJSA-N 0.000 description 1
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
- ZQFRDAZBTSFGGW-SRVKXCTJSA-N Asp-Ser-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZQFRDAZBTSFGGW-SRVKXCTJSA-N 0.000 description 1
- NJLLRXWFPQQPHV-SRVKXCTJSA-N Asp-Tyr-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O NJLLRXWFPQQPHV-SRVKXCTJSA-N 0.000 description 1
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- GGIHYKLJUIZYGH-ZLUOBGJFSA-N Cys-Cys-Asp Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)N)C(=O)O GGIHYKLJUIZYGH-ZLUOBGJFSA-N 0.000 description 1
- SKSJPIBFNFPTJB-NKWVEPMBSA-N Cys-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CS)N)C(=O)O SKSJPIBFNFPTJB-NKWVEPMBSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- TYRMVTKPOWPZBC-SXNHZJKMSA-N Gln-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCC(=O)N)N TYRMVTKPOWPZBC-SXNHZJKMSA-N 0.000 description 1
- FKXCBKCOSVIGCT-AVGNSLFASA-N Gln-Lys-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FKXCBKCOSVIGCT-AVGNSLFASA-N 0.000 description 1
- SGVGIVDZLSHSEN-RYUDHWBXSA-N Gln-Tyr-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O SGVGIVDZLSHSEN-RYUDHWBXSA-N 0.000 description 1
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 1
- OJGLIOXAKGFFDW-SRVKXCTJSA-N Glu-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N OJGLIOXAKGFFDW-SRVKXCTJSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 1
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- BXSZPACYCMNKLS-AVGNSLFASA-N Glu-Ser-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BXSZPACYCMNKLS-AVGNSLFASA-N 0.000 description 1
- FVGOGEGGQLNZGH-DZKIICNBSA-N Glu-Val-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FVGOGEGGQLNZGH-DZKIICNBSA-N 0.000 description 1
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 1
- YZPVGIVFMZLQMM-YUMQZZPRSA-N Gly-Gln-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CN YZPVGIVFMZLQMM-YUMQZZPRSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- OLPPXYMMIARYAL-QMMMGPOBSA-N Gly-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)CN OLPPXYMMIARYAL-QMMMGPOBSA-N 0.000 description 1
- ZKLYPEGLWFVRGF-IUCAKERBSA-N Gly-His-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZKLYPEGLWFVRGF-IUCAKERBSA-N 0.000 description 1
- LRQXRHGQEVWGPV-NHCYSSNCSA-N Gly-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN LRQXRHGQEVWGPV-NHCYSSNCSA-N 0.000 description 1
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 1
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 1
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 1
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
- NOQPTNXSGNPJNS-YUMQZZPRSA-N His-Asn-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O NOQPTNXSGNPJNS-YUMQZZPRSA-N 0.000 description 1
- LIEIYPBMQJLASB-SRVKXCTJSA-N His-Gln-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CN=CN1 LIEIYPBMQJLASB-SRVKXCTJSA-N 0.000 description 1
- LVXFNTIIGOQBMD-SRVKXCTJSA-N His-Leu-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O LVXFNTIIGOQBMD-SRVKXCTJSA-N 0.000 description 1
- LLZLRXBTOOFODM-QSFUFRPTSA-N Ile-Asp-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N LLZLRXBTOOFODM-QSFUFRPTSA-N 0.000 description 1
- PNDMHTTXXPUQJH-RWRJDSDZSA-N Ile-Glu-Thr Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@H](O)C)C(=O)O PNDMHTTXXPUQJH-RWRJDSDZSA-N 0.000 description 1
- YBGTWSFIGHUWQE-MXAVVETBSA-N Ile-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CC1=CN=CN1 YBGTWSFIGHUWQE-MXAVVETBSA-N 0.000 description 1
- CSQNHSGHAPRGPQ-YTFOTSKYSA-N Ile-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O)N CSQNHSGHAPRGPQ-YTFOTSKYSA-N 0.000 description 1
- SAVXZJYTTQQQDD-QEWYBTABSA-N Ile-Phe-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SAVXZJYTTQQQDD-QEWYBTABSA-N 0.000 description 1
- BATWGBRIZANGPN-ZPFDUUQYSA-N Ile-Pro-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)O)N BATWGBRIZANGPN-ZPFDUUQYSA-N 0.000 description 1
- PRTZQMBYUZFSFA-XEGUGMAKSA-N Ile-Tyr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCC(=O)O)N PRTZQMBYUZFSFA-XEGUGMAKSA-N 0.000 description 1
- WRDTXMBPHMBGIB-STECZYCISA-N Ile-Tyr-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 WRDTXMBPHMBGIB-STECZYCISA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- ZRLUISBDKUWAIZ-CIUDSAMLSA-N Leu-Ala-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O ZRLUISBDKUWAIZ-CIUDSAMLSA-N 0.000 description 1
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 1
- OXKYZSRZKBTVEY-ZPFDUUQYSA-N Leu-Asn-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OXKYZSRZKBTVEY-ZPFDUUQYSA-N 0.000 description 1
- WQWSMEOYXJTFRU-GUBZILKMSA-N Leu-Glu-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O WQWSMEOYXJTFRU-GUBZILKMSA-N 0.000 description 1
- XQXGNBFMAXWIGI-MXAVVETBSA-N Leu-His-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 XQXGNBFMAXWIGI-MXAVVETBSA-N 0.000 description 1
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 1
- FLNPJLDPGMLWAU-UWVGGRQHSA-N Leu-Met-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(C)C FLNPJLDPGMLWAU-UWVGGRQHSA-N 0.000 description 1
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 1
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 1
- TUIOUEWKFFVNLH-DCAQKATOSA-N Leu-Val-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(O)=O TUIOUEWKFFVNLH-DCAQKATOSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- JYVCOTWSRGFABJ-DCAQKATOSA-N Lys-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N JYVCOTWSRGFABJ-DCAQKATOSA-N 0.000 description 1
- LNMKRJJLEFASGA-BZSNNMDCSA-N Lys-Phe-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O LNMKRJJLEFASGA-BZSNNMDCSA-N 0.000 description 1
- AFLBTVGQCQLOFJ-AVGNSLFASA-N Lys-Pro-Arg Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AFLBTVGQCQLOFJ-AVGNSLFASA-N 0.000 description 1
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- RZJOHSFAEZBWLK-CIUDSAMLSA-N Met-Gln-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N RZJOHSFAEZBWLK-CIUDSAMLSA-N 0.000 description 1
- UYAKZHGIPRCGPF-CIUDSAMLSA-N Met-Glu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)N UYAKZHGIPRCGPF-CIUDSAMLSA-N 0.000 description 1
- ORRNBLTZBBESPN-HJWJTTGWSA-N Met-Ile-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ORRNBLTZBBESPN-HJWJTTGWSA-N 0.000 description 1
- HLZORBMOISUNIV-DCAQKATOSA-N Met-Ser-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C HLZORBMOISUNIV-DCAQKATOSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- YYRCPTVAPLQRNC-ULQDDVLXSA-N Phe-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC1=CC=CC=C1 YYRCPTVAPLQRNC-ULQDDVLXSA-N 0.000 description 1
- LWPMGKSZPKFKJD-DZKIICNBSA-N Phe-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O LWPMGKSZPKFKJD-DZKIICNBSA-N 0.000 description 1
- WFHRXJOZEXUKLV-IRXDYDNUSA-N Phe-Gly-Tyr Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 WFHRXJOZEXUKLV-IRXDYDNUSA-N 0.000 description 1
- HQCSLJFGZYOXHW-KKUMJFAQSA-N Phe-His-Cys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CS)C(=O)O)N HQCSLJFGZYOXHW-KKUMJFAQSA-N 0.000 description 1
- CWFGECHCRMGPPT-MXAVVETBSA-N Phe-Ile-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O CWFGECHCRMGPPT-MXAVVETBSA-N 0.000 description 1
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 1
- ZYNBEWGJFXTBDU-ACRUOGEOSA-N Phe-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N ZYNBEWGJFXTBDU-ACRUOGEOSA-N 0.000 description 1
- GOUWCZRDTWTODO-YDHLFZDLSA-N Phe-Val-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O GOUWCZRDTWTODO-YDHLFZDLSA-N 0.000 description 1
- OBVCYFIHIIYIQF-CIUDSAMLSA-N Pro-Asn-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OBVCYFIHIIYIQF-CIUDSAMLSA-N 0.000 description 1
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- OOZJHTXCLJUODH-QXEWZRGKSA-N Pro-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 OOZJHTXCLJUODH-QXEWZRGKSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- PZZJMBYSYAKYPK-UWJYBYFXSA-N Ser-Ala-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PZZJMBYSYAKYPK-UWJYBYFXSA-N 0.000 description 1
- CJINPXGSKSZQNE-KBIXCLLPSA-N Ser-Ile-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O CJINPXGSKSZQNE-KBIXCLLPSA-N 0.000 description 1
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 1
- LRWBCWGEUCKDTN-BJDJZHNGSA-N Ser-Lys-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LRWBCWGEUCKDTN-BJDJZHNGSA-N 0.000 description 1
- UGGWCAFQPKANMW-FXQIFTODSA-N Ser-Met-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O UGGWCAFQPKANMW-FXQIFTODSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- PRNGXSILMXSWQQ-OEAJRASXSA-N Thr-Leu-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PRNGXSILMXSWQQ-OEAJRASXSA-N 0.000 description 1
- MUAFDCVOHYAFNG-RCWTZXSCSA-N Thr-Pro-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MUAFDCVOHYAFNG-RCWTZXSCSA-N 0.000 description 1
- DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 1
- BCYUHPXBHCUYBA-CUJWVEQBSA-N Thr-Ser-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BCYUHPXBHCUYBA-CUJWVEQBSA-N 0.000 description 1
- NQQMWWVVGIXUOX-SVSWQMSJSA-N Thr-Ser-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NQQMWWVVGIXUOX-SVSWQMSJSA-N 0.000 description 1
- BKVICMPZWRNWOC-RHYQMDGZSA-N Thr-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O BKVICMPZWRNWOC-RHYQMDGZSA-N 0.000 description 1
- QNJYPWZACBACER-KKUMJFAQSA-N Tyr-Asp-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O QNJYPWZACBACER-KKUMJFAQSA-N 0.000 description 1
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 1
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 1
- PRONOHBTMLNXCZ-BZSNNMDCSA-N Tyr-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PRONOHBTMLNXCZ-BZSNNMDCSA-N 0.000 description 1
- HSBZWINKRYZCSQ-KKUMJFAQSA-N Tyr-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O HSBZWINKRYZCSQ-KKUMJFAQSA-N 0.000 description 1
- IDKGBVZGNTYYCC-QXEWZRGKSA-N Val-Asn-Pro Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O IDKGBVZGNTYYCC-QXEWZRGKSA-N 0.000 description 1
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 1
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 1
- LKUDRJSNRWVGMS-QSFUFRPTSA-N Val-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LKUDRJSNRWVGMS-QSFUFRPTSA-N 0.000 description 1
- UXODSMTVPWXHBT-ULQDDVLXSA-N Val-Phe-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N UXODSMTVPWXHBT-ULQDDVLXSA-N 0.000 description 1
- JQTYTBPCSOAZHI-FXQIFTODSA-N Val-Ser-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N JQTYTBPCSOAZHI-FXQIFTODSA-N 0.000 description 1
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 231100000221 frame shift mutation induction Toxicity 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 108010073628 glutamyl-valyl-phenylalanine Proteins 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- 108010078326 glycyl-glycyl-valine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 108010012581 phenylalanylglutamate Proteins 0.000 description 1
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
- C12N5/0659—Satellite cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides application of a pig RagC gene. The invention designs a specific primer according to the homology of a human RagC gene sequence and a mouse RagC gene sequence, clones pig RagC gene ORF for the first time, and applies and explores the function of the pig RagC gene participating in induction of different amino acids in different histiocytes of a pig. The invention discovers that the over-expression RagC gene participates in the expression level of the lysine activated porcine skeletal muscle satellite cell mTORC1 signal channel protein, and can obviously improve the protein synthesis capacity of the porcine skeletal muscle satellite cell; the RagC gene is suggested to be involved in the process that mTORC1 senses the change of lysine concentration to regulate and control the synthesis of skeletal muscle satellite cell protein and promote the growth of pig muscle.
Description
Technical Field
The invention belongs to the technical field of molecular biology. More particularly, it relates to the application of pig RagC gene.
Background
The mTORC1 can sense the concentration change of intracellular and extracellular amino acids, and further mediate the amino acids to regulate and control protein synthesis. RagC is an important target protein for recruitment of mTORC1 to lysosomal activation. However, the pathways of mTORC1 activation by different amino acids are different, and the pathways of mTORC1 activation by amino acids are not completely consistent among different cells. RagC is one of the members of Rag GTPase, and the other 3 members in mammals are RagA, ragB and RagD respectively, and all belong to the Ras small G protein family. The RagA and RagB are highly homologous, and the RagC and RagD are highly homologous, and the RagA or RagB can be combined with the RagC or RagD to form a heterodimer. Existing studies demonstrate that Rag GTPase is able to mediate amino acid activation of the mTORC1 signaling pathway, particularly leucine and arginine.
Patent CN111394370A discloses a pig RagA gene and application thereof, and particularly discloses that overexpression of the RagA gene can remarkably increase the activity of intestinal epithelial cells and simultaneously activate a mTORC1 signal pathway. However, at present, research on RagC genes at home and abroad is concentrated on human, mice and yeast, and research on pig RagC genes is not reported, and particularly, application of RagC participating in activation of mTORC1 signal channels in different histiocytes of pigs by different amino acids is unknown. In the process of resolving amino acid sensing, functional studies of RagC are crucial, however, there are studies that suggest that the involvement of RagC is not required for glutamine activation of mTORC 1. Therefore, it is necessary to carry out systematic research on the function of amino acid induction of the RagC gene in porcine histiocytes, and an important basis is provided for the subsequent application of the porcine RagC gene in improving the growth quality of pigs.
Disclosure of Invention
The invention aims to solve the technical problem of overcoming the defects of the pig RagC gene in the research of the functions of pig cells in the prior art and provides the application of the pig RagC gene.
The first purpose of the invention is to provide the application of pig RagC gene in improving the protein synthesis capacity of animal cells.
The second purpose of the invention is to provide the application of the pig RagC gene and/or the protein coded by the pig RagC gene as mTORC1 pathway activator for improving the protein synthesis capability of animal cells.
The third purpose of the invention is to provide the application of the pig RagC gene and/or the protein coded by the pig RagC gene in promoting the growth of animal muscle.
The fourth purpose of the invention is to provide a method for improving the protein synthesis capability of the pig cells.
The above object of the present invention is achieved by the following technical solutions:
the invention designs specific primers according to the homology of a human RagC gene sequence and a mouse RagC gene sequence, clones a pig RagC gene for the first time, the nucleotide sequence of the pig RagC gene is shown as SEQ ID NO.5, and the application and the exploration are carried out on the function of the pig RagC gene participating in the induction of different amino acids in different histiocytes of pigs. The invention discovers that the over-expression of the RagC gene is involved in the expression level of the protein of the mTORC1 signal pathway of the pig skeletal muscle satellite cell activated by lysine, but the over-expression of the RagC gene is not involved in the mTORC1 signal pathway of the pig intestinal epithelial cell activated by glutamic acid, which indicates that the functions of the RagC in different cells involved in different amino acid sensing are different.
The invention therefore claims the following applications:
the application of pig RagC gene in improving the protein synthesis capacity of animal cells.
The application of the pig RagC gene and/or the protein coded by the pig RagC gene in the improvement of the protein synthesis capability of animal cells as mTORC1 pathway activators.
Preferably, the animal cell is a porcine tissue cell.
More preferably, the porcine tissue cells are porcine skeletal muscle satellite cells.
The nucleotide sequence of the pig RagC gene is shown as SEQ ID NO.5, and the amino acid sequence of the encoded protein is shown as SEQ ID NO. 6.
Likewise, the application of the pig RagC gene and/or the protein coded by the pig RagC gene in promoting the muscle growth of animals is also within the protection scope of the invention.
Preferably, the animal is a pig.
Preferably, the above-described application is the overexpression of the porcine RagC gene in porcine skeletal muscle satellite cells.
A method for increasing protein synthesis ability of a pig cell, which comprises over-expressing a pig RagC gene in the pig cell, comprising the steps of:
s1, amplifying the pig RagC gene ORF by PCR;
s2, constructing a lentivirus over-expression vector containing a pig RagC gene ORF;
s3, infecting the pig cells with the lentivirus overexpression vector obtained in the step S2 to obtain a pig cell strain which expresses a pig RagC gene.
Preferably, the porcine cells are porcine skeletal muscle satellite cells.
Preferably, the nucleotide sequence of the primer amplified by PCR in step S1 is shown in SEQ ID NO. 1-2.
Preferably, the plasmid used for constructing the lentiviral over-expression vector containing the porcine RagC gene ORF in the step S2 is pLVX-AcGFP1-N1.
Preferably, real-time PCR is adopted to identify whether an over-expression cell strain of the RagC gene is obtained or not, and the sequence of a primer used for identifying the over-expression of the RagC gene by PCR is shown in SEQ ID NO. 7-8.
The invention has the following beneficial effects:
the invention provides a new application of pig RagC gene. According to the invention, a specific primer is designed according to homology of a human RagC gene sequence and a mouse RagC gene sequence, the pig RagC gene ORF is cloned for the first time, and the application and exploration are carried out on the function of the pig RagC gene participating in induction of different amino acids in different histiocytes of a pig. The invention discovers that the over-expression RagC gene participates in the expression level of the lysine activated porcine skeletal muscle satellite cell mTORC1 signal channel protein, and can obviously improve the protein synthesis capacity of the porcine skeletal muscle satellite cell; the result suggests that the gene of RagC participates in the process that mTORC1 senses the change of lysine concentration to regulate and control the synthesis of skeletal muscle satellite cell protein and promote the growth of pig muscle, and can be used for the subsequent functional research of the RagC gene of pigs on pig animals and the development of amino acid sensing.
Drawings
FIG. 1 is a diagram showing the result of electrophoresis of a PCR amplification product of the RagC gene; in the figure, M: DNA Marker DL2000,1 and 2: the target strand of RagC (1200 bp).
FIG. 2 is a diagram showing the results of cutting gel and recovering the RagC gene after agarose gel electrophoresis; in the figure, M: DNA Marker DL2000,1: the target strand of RagC (1200 bp).
FIG. 3 is a diagram showing the result of electrophoresis of a PCR amplification product of the ragC gene having a restriction enzyme cleavage site and a Flag tag; in the figure, M: DNA Marker DL2000,1: contains a RagC gene band (1247 bp).
FIG. 4 is a diagram showing the results of recovering the RagC gene with the cleavage site and Flag tag by cutting; in the figure, M: DNA Marker DL2000,1: contains the RagC gene band (1247 bp).
FIG. 5 is a graph showing the results of the purified and recovered RagC gene after Xho I and EcoR I double digestion; in the figure, M: DNA Marker DL2000,1: contains the RagC gene band (1241 bp).
FIG. 6 is a diagram showing the results of the purification and recovery of pLVX-AcGFP1-N1 fragment by Xho I and EcoR I; in the figure, M1: DNA Marker DL15000,1: pLVX-AcGFP1-N1 fragment (8771 bp).
FIG. 7 is a result diagram of the recombinant vector obtained by enzyme digestion identification; in the figure, M2: DNA Marker DL10000,1 and 2 are respectively used for identifying the recombinant vector (10012 bp) by single enzyme digestion of Xho I and EcoR I restriction enzymes, and 3 is used for identifying the recombinant vector (8771 bp) by double enzyme digestion of Xho I and EcoR I restriction enzymes.
FIG. 8 is a graph of the sequencing peaks of RagC in the recombinant overexpression vector (CMV-F one-way sequencing).
Fig. 9 shows GFP positive cells obtained using the MoFlo XDP ultra-flow cytometric sorting system, negative control: negative Control group (wild type porcine intestinal epithelial cells), control: control group (empty plasmid group, expression GFP tag), ragC overlay: ragC overexpression panel (expression GFP tag).
FIG. 10 is a graph showing the intensity of GFP fluorescence signals observed after sorting in the control group and the RagC overexpression group.
Fig. 11 is the identification of stable transgenic porcine intestinal epithelial cell line overexpressing RagC, a: ragC fluorescence signal intensity, B: mRNA abundance and C: protein expression level (n = 3); wherein, control: control group (empty plasmid group), ragC overlay expression: ragC overexpression group.
FIG. 12 shows that immunofluorescence identifies that the Flag tag is simultaneously over-expressed in the RagC stably transfected porcine intestinal epithelial cell line.
Figure 13 is a graph showing that glutamate activates mTORC1 signaling in porcine intestinal epithelial cells and down-regulates the level of RagC total protein expression.
Figure 14 is that RagC is not involved in glutamate activation of mTORC1 signaling events in porcine intestinal epithelial cells.
Fig. 15 is a graph showing that lysine up-regulates porcine skeletal muscle satellite cell RagC protein expression levels and activates the mTORC1 signaling pathway.
FIG. 16 shows the GFP fluorescence signal intensity of control and RagC-overexpressing groups after stable transformation of porcine skeletal muscle satellite cells by overexpression of RagC.
FIG. 17 shows that overexpression of RagC significantly increases the expression level of mTORC1 signal pathway protein of porcine skeletal muscle satellite cells.
FIG. 18 shows that overexpression of RagC significantly improves the protein synthesis capacity of porcine skeletal muscle satellite cells.
Detailed Description
The invention is further described with reference to the following detailed description and accompanying drawings, but the invention is not limited thereto in any way. The reagents, methods and apparatus employed in the present invention are conventional in the art, except as otherwise indicated. Unless otherwise indicated, reagents and materials used in the following examples are commercially available.
Example 1 PCR amplification of porcine RagC Gene ORF
1. Primer design
Based on the homology between the human ragC gene sequence (accession No. NM-022157.4) and the mouse ragC gene sequence (accession No. NM-017475.2), specific primers F1/R1 were designed using Primer Premier 5 software, and the nucleotide sequences of the primers are shown in Table 1.
TABLE 1 nucleotide sequences of primers for cloning
2. Extraction of total RNA of porcine intestinal epithelial cells
The culture medium in the 6-well plate was aspirated and the cells rinsed twice with PBS. Adding 1mL Trizol reagent into each hole, standing for 5min at room temperature, centrifuging for 10min at 12000r/min at 4 ℃, and taking supernatant to a new centrifuge tube. Adding 0.2mL of chloroform, shaking vigorously and mixing uniformly, standing at room temperature for 5min, centrifuging at 4 ℃ for 15min at 12000r/min (the speed reduction is zero), and taking the upper-layer water phase to a new centrifuge tube. Adding isopropanol according to the proportion of 1. The RNA precipitate was rinsed 2 times with 75% ethanol, centrifuged at 12000r/min at 4 ℃ for 5min, and the supernatant was discarded. Standing at room temperature, drying the precipitate, and adding a proper amount of DEPC water for dissolving. The RNA concentration was measured by a nucleic acid protein analyzer, and the quality of the RNA was checked by ordinary agarose gel electrophoresis.
3. Digestion of DNA in total RNA of porcine intestinal epithelial cells
The ingredients were added and mixed uniformly in the digestion reaction system shown in Table 2, reacted at 37 ℃ for 30min and at 65 ℃ for 5min (inactivating DNase) to digest DNA in total RNA of porcine small intestine epithelial cells.
TABLE 2 digestion reaction System
4. cDNA Synthesis
Reverse transcription was performed according to M-MLV reagent instructions, taking 2. Mu.g of RNA, adding 3. Mu.L of random primer, adding DEPC water to 15. Mu.L, denaturing at 70 ℃ for 5min, cooling on ice, and centrifuging briefly. Then adding other components according to a reverse transcription reaction system shown in the table 3, oscillating, uniformly mixing, centrifuging for a short time, and standing for 60min at 37 ℃; inactivating at 80 deg.C for 5min, standing at 12 deg.C for 10min, subpackaging, and storing at-20 deg.C.
TABLE 3 reverse transcription reaction System
5. PCR amplification of porcine RagC gene ORF
(1) Experimental method
And (3) taking the cDNA obtained in the step (4) as a template, and amplifying the pig RagC gene by using the specific primer designed in the step (1) through a PCR amplification system shown in a table 4.
TABLE 4 CDS region system amplification
(2) Recovery of PCR amplification products
Preparing 1.2% agarose gel, carrying out agarose electrophoresis for 30min at 110V after spotting the PCR amplification product, and taking a picture by a gel imaging system after the electrophoresis is finished. Then, the agarose gel with the target fragment was excised, and the target fragment was recovered using an agarose gel recovery kit (TIANGEN DP 209) according to the kit instructions.
(3) Results of the experiment
FIGS. 1 and 2 show that the PCR amplification product of the RagC gene and the size of the RagC gene recovered by cutting gel after agarose gel electrophoresis are 1200bp.
6. PCR amplification of pig RagC gene ORF containing enzyme cutting site
(1) Design of pig RagC gene amplification primer containing enzyme cutting site
A pair of primers F2/R2 is designed at two ends of the ORF of the RagC gene, the nucleotide sequence of the primers is shown in Table 5, an upstream primer has an Xho I enzyme cutting site, and a downstream primer has an EcoR I enzyme cutting site. For later functional verification, a Kozak sequence (for enhancing the expression of a target gene) and a Flag tag are added into an upstream primer, 3 bases of CTA (CTA) are removed from a downstream primer, so that amplified RagC gene ORF and a connected vector GFP are subjected to fusion expression, and G bases are added at the same time, so that no frameshift mutation is generated.
TABLE 5 nucleotide sequences of primers for cloning
(2) Results of the experiment
As shown in FIGS. 3 and 4, the PCR amplification product of the ragC gene with the restriction enzyme site and Flag tag and the size of the ragC gene with the restriction enzyme site and Flag tag recovered from the gel cutting were all 1247bp.
7. Amplification extraction of pLVX-AcGFP1-N1 plasmid
Inoculating a bacterial liquid containing a lentivirus overexpression vector pLVX-AcGFP1-N1 on a LA plate, culturing overnight at 37 ℃, picking a single colony from the LA plate by using a sterilized toothpick after the colony grows out, inoculating the single colony in 5mL LA liquid culture medium, and shaking overnight at 37 ℃. Plasmids were extracted by the method of reference plasmid miniprep kit (TIANGEN DP 103).
8. Recovering double enzyme digestion target fragment sequence and slow virus over-expression vector
(1) Experimental methods
Referring to the recovery method of the DNA product in the step 5, the target fragment is recovered, double enzyme digestion of the target fragment and the vector is performed according to the reaction system shown in Table 6, and after enzyme digestion, the Universal DNA purification recovery kit (TIANGEN DP 214) is used for recovery, and the recovery is performed according to the method of the kit specification.
TABLE 6 double digestion reaction System
(2) Results of the experiment
The experimental results are shown in FIG. 5 and FIG. 6, the size of the purified and recovered RagC gene after Xho I and EcoR I double digestion is 1241bp, and the size of the purified and recovered pLVX-AcGFP1-N1 fragment after Xho I and EcoR I double digestion is 8771bp.
9. Ligation reaction
The pLVX-AcGFP1-N1 and the RagC fragment double enzyme digestion products are uniformly mixed according to a reaction system shown in the table 7, the mixture is placed in an environment at 16 ℃ for overnight connection, the result of the recombinant vector obtained by enzyme digestion identification is shown in the figure 7, and the size of the recombinant vector is 10012bp.
TABLE 7 ligation reaction System of pLVX-AcGFP1-N1 and RagC Gene fragments
10. Transformation of Escherichia coli stbl3 competent cells by ligation product
And (3) uniformly mixing 10 mu L of the ligation product with 50 mu L of stbl3 competent cells, carrying out ice bath for 30min, carrying out heat shock for 45s at 42 ℃, standing on ice for 3-5 min, adding 600 mu L of antibiotic-free LB culture medium, and shaking for 1h at 37 ℃ at 250 r/min. Spreading on LA plate surface with 200 μ L sterile glass spreader, standing at 37 deg.C for 20min, and culturing for 12h.
11. Sequencing
(1) Experimental method
And after transformation and single bacterium selection of the ligation product, carrying out amplification and extraction on the operation of the plasmid, carrying out PCR identification on the extracted recombinant plasmid, and selecting a bacterial solution with positive enzyme digestion identification and sending the bacterial solution to Guangzhou Scout Biotechnology Limited company for sequencing. After the result is determined, the positive bacteria liquid is taken and extracted with a Kangji corporation endotoxin-free Plasmid Maxi Kit (CWBIO CW 2104) to obtain plasmids, and the plasmids are stored at-20 ℃ for later use after the concentration is measured.
(2) Results of the experiment
Sequencing the obtained recombinant plasmid pLVX-Flag-RagC-AcGFP1-N1, wherein a sequencing peak diagram is shown in figure 8, a nucleotide sequence of the porcine RagC gene obtained after sequencing is shown in SEQ ID No.5, and an amino acid sequence of the protein coded by the ORF is shown in SEQ ID No. 6.
Example 2 construction of cell line overexpressing pig RagC Gene
1. Construction of porcine RagC overexpression vector
The successfully sequenced recombinant plasmid pLVX-Flag-RagC-AcGFP1-N1 in the example 1 is used as a pig RagC gene overexpression vector, and the amplification and plasmid extraction are the same as those in the example 1.
2. The transformation, amplification and extraction methods of the lentiviral vector helper plasmids pMD2.G and psPAX2 are the same as those in example 1, except that the cells used for transformation are Escherichia coli DH5 alpha competent cells.
3. Culture and passage of 293T cell of lentivirus packaging cell
Resuspending the cells in complete medium (high-glucose DMEM medium containing 10% FBS and 1% penicillin/streptomycin), inoculating into a flask, incubating at 37 deg.C, saturation humidity, 5% CO 2 Cultured in an incubator.
When the fusion rate of the 293T cell reaches 90%, the passage is carried out by the following specific method: the medium was aspirated, rinsed 1 time with PBS, and digested with 0.25% trypsin solution for 4min. The trypsin solution was aspirated off, an equal volume of complete medium was added to stop digestion, and the cell suspension was transferred to a 10mL centrifuge tube and centrifuged at 1000r/min at 4 ℃ for 3min. The supernatant was aspirated off, the cells were resuspended in complete medium, inoculated into a new flask and cultured as 1.
4. Lentiviral packaging
The recombinant plasmid pLVX-Flag-RagC-AcGFP1-N1 and the empty plasmid pLVX-AcGFP1-N1 are co-transfected into 293T cells together with a lentivirus packaging helper plasmid pMD2.G and psPAX2 respectively to carry out lentivirus packaging (the mass ratio of the recombinant plasmid to the lentivirus packaging helper plasmid is pLVX-RagC-AcGFP1-N1: psPAX2: pMD2.G = 3).
5. Obtaining an overexpression porcine RagC stable transgenic cell strain
(1) Experimental methods
Infecting pig intestinal epithelial cells and pig skeletal muscle satellite cells with the harvested lentivirus particles, screening by a flow cytometry and a puromycin drug (2.5 mu g/mL and 3 mu g/mL respectively) to obtain pig intestinal epithelial cells and pig skeletal muscle satellite cells of stably-transformed pig RagC, and identifying RagC overexpression by applying a cellular immunofluorescence technique, real-time PCR and Western blotting to show whether the stably-transformed pig intestinal epithelial cells and pig skeletal muscle satellite cells over-expressing the RagC gene are obtained; wherein, the primer F3/R3 and the sequence thereof used for identifying the overexpression of the RagC gene by Real-time PCR are shown in the table 8.
TABLE 8 primers and sequences thereof for Real-time PCR identification of overexpression of RagC gene
(2) Results of the experiment
The results are shown in FIGS. 9 to 12, which indicate that stable porcine intestinal epithelial cells and porcine skeletal muscle satellite cells overexpressing RagC have been obtained. From the area size of the R3 region in FIG. 9 and the detectable GFP green fluorescence signal in FIG. 10, ragC overexpression can be successfully found; FIG. 11 shows that a stably transformed porcine intestinal epithelial cell line with over-expressed RagC has been obtained; fig. 12 suggests successful RagC overexpression in porcine skeletal muscle satellite cells.
Example 3 functional verification of the porcine RagC Gene
1. Function of RagC gene after over-expression in pig intestinal epithelial cell
(1) Experimental methods
Uses pig intestine epithelial cell line as material, 5 x 10 4 6-well cell culture plates are inoculated on each cell/well, after 24h of adherence, 15h of serum starvation and 4h of amino acid starvation, the cells are divided into a control group (0 mmol/L) and a glutamic acid group (5 mmol/L) for treatment, and cell protein samples are collected. Detecting the expression level of key protein of mTORC1 signal channel and the expression level of RagC by western blotting; secondly, wild type, empty plasmid and RagC overexpressing cells were used as test materials, 5X 10 4 And inoculating 6-well cell culture plates into each cell/well, treating the cells by dividing the cells into a control group (0 mmol/L) and a glutamic acid group (5 mmol/L), collecting cell protein samples, detecting the expression level of key proteins of the mTORC1 signal pathway through western blotting, and observing the influence of the RagC gene on the mTORC1 signal pathway after the RagC gene is over-expressed in porcine intestinal epithelial cells.
(2) Results of the experiment
The results are shown in fig. 13 and 14, which indicate that glutamate treatment activates mTORC1 signaling in porcine intestinal epithelial cells (fig. 13A-B) and down-regulates the level of RagC total protein expression (fig. 13C-D); the results in fig. 14 show that the over-expression of the RagC gene is not involved in the mTORC1 signaling event in glutamate-activated porcine intestinal epithelial cells.
2. Function of RagC gene after over-expression in pig skeletal muscle satellite cell
(1) Experimental method
Using pig skeletal muscle satellite cell as material, and using 5X 10 4 Inoculating 6-well cell culture plates to each cell/well, and detecting the influence of lysine (0, 0.25, 0.5 and 1 mmol/L) treatment with different concentrations on the key protein expression and RagC expression level of the mTORC1 signal pathway after 24-hour adherence, 15-hour serum starvation and 4-hour amino acid starvation; secondly, the influence of RagC gene overexpression on the expression of key proteins of mTORC1 signal pathway and the expression level of RagC in pig skeletal muscle satellite cells is detected.
(2) Results of the experiment
The results are shown in fig. 15-17, and the results in fig. 15 show that 0.50mmol/L lysine significantly improves the expression level of the total protein of the porcine skeletal muscle satellite cell RagC and activates the mTORC1 signal pathway; FIG. 16 shows that RagC gene was successfully overexpressed in porcine skeletal muscle satellite cells; the results of FIG. 17 show that the overexpression of the RagC gene remarkably improves the protein expression level of the mTORC1 signal pathway of porcine skeletal muscle satellite cells.
3. Effect of overexpression of RagC on protein synthesis ability of skeletal muscle satellite cells of pigs
(1) Experimental methods
Takes empty plasmid and RagC over-expression pig skeletal muscle satellite cell as materials, and takes 5 multiplied by 10 4 6-well cell culture plates were inoculated per cell/well, and after 48 hours of culture, 1.00. Mu.g/ml puromycin was added for 30min of treatment. Cell samples were collected from RIPA lysates and puromycin levels were detected by Western blotting to determine protein synthesis in porcine skeletal muscle satellite cells.
(2) Results of the experiment
The result is shown in figure 18, and the over-expression of RagC remarkably improves the protein synthesis capacity of porcine skeletal muscle satellite cells. The over-expression of the RagC gene is involved in the lysine-activated pig skeletal muscle satellite cell mTORC1 event, and the fact that the RagC gene is involved in the process that the mTORC1 senses the change of lysine concentration to regulate the synthesis of skeletal muscle satellite cell protein and promote the growth of pig muscles is suggested.
The invention proves that the functions of RagC participating in different amino acid induction in different cells are different, and the gene of RagC can participate in mTORC1 induced lysine concentration change so as to regulate and control the synthesis of pig skeletal muscle satellite cell protein, and can be used for the subsequent functional research of pig RagC gene in pig animals and the development of amino acid induction.
It should be finally noted that the above examples are only intended to illustrate the technical solutions of the present invention, and not to limit the scope of the present invention, and that other variations and modifications based on the above description and thought may be made by those skilled in the art, and that all embodiments need not be exhaustive. Any modification, equivalent replacement, and improvement made within the spirit and principle of the present invention should be included in the protection scope of the claims of the present invention.
Sequence listing
<110> southern China university of agriculture
Application of <120> pig RagC gene
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atgtccctgc agtacggggc ag 22
<210> 2
<211> 23
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
ctagatggca tttcgcggcg tgc 23
<210> 3
<211> 59
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
ccctcgaggc caccatggat tacaaggatg acgacgataa gatgtccctg cagtacggg 59
<210> 4
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
cggaattcgg atggcatttc gcggc 25
<210> 5
<211> 1200
<212> DNA
<213> porcine RagC gene ORF
<400> 5
atgtccctgc agtacggggc agaggagacg cccctcgccg gcagttacgg cgcggcggac 60
tcgttcccaa aggacttcgg ctacggcgtg gaggaggagg aagaggaggc tgcagccggg 120
ggtggcgggg ttggggcggg ggccggtgga ggctgtggcc cggggggtgc tgacagctcc 180
aagccgagga ttctgctcat ggggctccgg cgcagcggca agtcttccat ccagaaggtg 240
gtgtttcata aaatgtcgcc caatgagacc ctctttttgg aaagtaccaa caagatttac 300
aaagatgaca tttctaatag ctcctttgtg aatttccaaa tatgggattt tcctgggcaa 360
atggactttt ttgacccaac ttttgactat gagatgatct tcaggggaac aggagcattg 420
atatatgtca ttgatgcaca ggatgactac atggaggctt taacaagact tcacattact 480
gtttctaaag cctacaaagt taatccagac atgaattttg aggtttttat tcacaaagtt 540
gatggtctgt ctgatgatca caaaatagaa acacagaggg atattcatca aagggccaat 600
gatgaccttg cagatgctgg gctagaaaaa ctccacctta gcttttattt gactagtatc 660
tatgaccatt caatatttga agccttcagt aaggtggtgc agaaacttat tccacaactg 720
ccaaccctgg aaaacctatt aaatatcttt atatcaaatt caggtattga aaaagctttt 780
ctcttcgatg ttgtcagcaa aatctacatt gcaaccgaca gttctcctgt ggatatgcag 840
tcttatgaac tttgctgtga catgattgat gttgtaattg atgtgtcttg tatatatggg 900
ttaaaggaag atggaagtgg aagtgcttat gacaaagaat ctatggccat catcaagctg 960
aataatacaa ctgttcttta tttaaaggag gtgactaaat ttttggcact ggtctgcatt 1020
cttagggaag aaagttttga acgaaaaggt ttaatagact acaacttcca ctgtttccgt 1080
aaagctattc atgaggtttt tgaggttggt gtgacttctc acaggagctg tggtcaccag 1140
agcagtgccc ccagcctgaa agcgttgaca cacaacggca cgccgcgaaa tgccatctag 1200
<210> 6
<211> 399
<212> PRT
<213> porcine RagC protein
<400> 6
Met Ser Leu Gln Tyr Gly Ala Glu Glu Thr Pro Leu Ala Gly Ser Tyr
1 5 10 15
Gly Ala Ala Asp Ser Phe Pro Lys Asp Phe Gly Tyr Gly Val Glu Glu
20 25 30
Glu Glu Glu Glu Ala Ala Ala Gly Gly Gly Gly Val Gly Ala Gly Ala
35 40 45
Gly Gly Gly Cys Gly Pro Gly Gly Ala Asp Ser Ser Lys Pro Arg Ile
50 55 60
Leu Leu Met Gly Leu Arg Arg Ser Gly Lys Ser Ser Ile Gln Lys Val
65 70 75 80
Val Phe His Lys Met Ser Pro Asn Glu Thr Leu Phe Leu Glu Ser Thr
85 90 95
Asn Lys Ile Tyr Lys Asp Asp Ile Ser Asn Ser Ser Phe Val Asn Phe
100 105 110
Gln Ile Trp Asp Phe Pro Gly Gln Met Asp Phe Phe Asp Pro Thr Phe
115 120 125
Asp Tyr Glu Met Ile Phe Arg Gly Thr Gly Ala Leu Ile Tyr Val Ile
130 135 140
Asp Ala Gln Asp Asp Tyr Met Glu Ala Leu Thr Arg Leu His Ile Thr
145 150 155 160
Val Ser Lys Ala Tyr Lys Val Asn Pro Asp Met Asn Phe Glu Val Phe
165 170 175
Ile His Lys Val Asp Gly Leu Ser Asp Asp His Lys Ile Glu Thr Gln
180 185 190
Arg Asp Ile His Gln Arg Ala Asn Asp Asp Leu Ala Asp Ala Gly Leu
195 200 205
Glu Lys Leu His Leu Ser Phe Tyr Leu Thr Ser Ile Tyr Asp His Ser
210 215 220
Ile Phe Glu Ala Phe Ser Lys Val Val Gln Lys Leu Ile Pro Gln Leu
225 230 235 240
Pro Thr Leu Glu Asn Leu Leu Asn Ile Phe Ile Ser Asn Ser Gly Ile
245 250 255
Glu Lys Ala Phe Leu Phe Asp Val Val Ser Lys Ile Tyr Ile Ala Thr
260 265 270
Asp Ser Ser Pro Val Asp Met Gln Ser Tyr Glu Leu Cys Cys Asp Met
275 280 285
Ile Asp Val Val Ile Asp Val Ser Cys Ile Tyr Gly Leu Lys Glu Asp
290 295 300
Gly Ser Gly Ser Ala Tyr Asp Lys Glu Ser Met Ala Ile Ile Lys Leu
305 310 315 320
Asn Asn Thr Thr Val Leu Tyr Leu Lys Glu Val Thr Lys Phe Leu Ala
325 330 335
Leu Val Cys Ile Leu Arg Glu Glu Ser Phe Glu Arg Lys Gly Leu Ile
340 345 350
Asp Tyr Asn Phe His Cys Phe Arg Lys Ala Ile His Glu Val Phe Glu
355 360 365
Val Gly Val Thr Ser His Arg Ser Cys Gly His Gln Ser Ser Ala Pro
370 375 380
Ser Leu Lys Ala Leu Thr His Asn Gly Thr Pro Arg Asn Ala Ile
385 390 395
<210> 7
<211> 23
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
acagagggat attcatcaaa ggg 23
<210> 8
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
ggttggcagt tgtggaataa gt 22
Claims (3)
1. The application of pig RagC gene in improving the protein synthesis capacity of animal cells is characterized in that the animal cells are pig skeletal muscle satellite cells; the application is that pig RagC genes are over-expressed in pig skeletal muscle satellite cells; the nucleotide sequence of the RagC gene is shown as SEQ ID NO. 5.
2. Use of a porcine RagC gene and/or its encoded protein for promoting muscle growth in an animal, wherein the animal is a pig; the application is that the pig RagC gene is over-expressed in pig skeletal muscle satellite cells; the nucleotide sequence of the RagC gene is shown as SEQ ID NO.5, and the amino acid sequence of the encoded protein is shown as SEQ ID NO. 6.
3. A method for improving the protein synthesis capability of a pig cell, which is characterized in that the pig RagC gene is over-expressed in the pig cell, and the method comprises the following steps:
s1, PCR amplification of pig RagC gene ORF;
s2, constructing a lentivirus over-expression vector containing a pig RagC gene ORF;
s3, infecting the pig cells with the lentivirus overexpression vector obtained in the step S2 to obtain a pig cell strain which expresses a pig RagC gene;
the pig cell is a pig skeletal muscle satellite cell; the nucleotide sequence of the RagC gene is shown as SEQ ID NO. 5; the nucleotide sequence of the primer amplified by the PCR in the step S1 is shown as SEQ ID NO. 1-2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110034472.9A CN112779262B (en) | 2021-01-11 | 2021-01-11 | Application of pig RagC gene |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110034472.9A CN112779262B (en) | 2021-01-11 | 2021-01-11 | Application of pig RagC gene |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112779262A CN112779262A (en) | 2021-05-11 |
CN112779262B true CN112779262B (en) | 2023-04-18 |
Family
ID=75757045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110034472.9A Active CN112779262B (en) | 2021-01-11 | 2021-01-11 | Application of pig RagC gene |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112779262B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115927459A (en) * | 2022-07-19 | 2023-04-07 | 华南农业大学 | Application of pig CTNS gene in promoting growth of animal skeletal muscle |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015168617A2 (en) * | 2014-05-02 | 2015-11-05 | Whitehead Institute For Biomedical Research | Compositions and methods for modulating mtorc1 |
CN111394370A (en) * | 2020-03-03 | 2020-07-10 | 华南农业大学 | Pig RagA gene and application thereof |
-
2021
- 2021-01-11 CN CN202110034472.9A patent/CN112779262B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015168617A2 (en) * | 2014-05-02 | 2015-11-05 | Whitehead Institute For Biomedical Research | Compositions and methods for modulating mtorc1 |
CN111394370A (en) * | 2020-03-03 | 2020-07-10 | 华南农业大学 | Pig RagA gene and application thereof |
Non-Patent Citations (4)
Title |
---|
Differential regulation of mTORC1 activation by leucine and β-hydroxy-β-methylbutyrate in skeletal muscle of neonatal pigs;Agus Suryawan 等;《J Appl Physiol》;20200201;第128卷(第2期);286-295 * |
mTORC1通路中氨基酸信号转导相关机制研究进展;高源等;《中国细胞生物学学报》;20120815;第34卷(第08期);812-818 * |
NCBI Reference Sequence: XM_003127801.4 Sus scrofa Ras related GTP binding C (RRAGC), mRNA;GENBANK;《NCBI》;20170513;1-2 * |
Regulation of Muscle Growth in Early Postnatal Life in a Swine Model;Marko Rudar 等;《Annu Rev Anim Biosci》;20190215;第7卷;1-33 * |
Also Published As
Publication number | Publication date |
---|---|
CN112779262A (en) | 2021-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107501405B (en) | Autophagy inhibiting polypeptide | |
CN112779262B (en) | Application of pig RagC gene | |
CN114058619A (en) | Construction of RIPLET knockout cell line and application of RIPLET knockout cell line as production cell line of picornaviridae virus vaccine | |
CN108794638A (en) | A kind of recombinant bovine long-acting interferon α and the fusion protein and preparation method thereof for preparing this long-acting interferon | |
CN117224669A (en) | Application of African swine fever virus MGF360-21R protein as immunity inducer or adjuvant | |
CN111394370B (en) | Pig RagA gene and application thereof | |
CN115820693A (en) | Lentiviral system for stably expressing coronavirus 3CL protease, cell model, construction method and application | |
CN110669144B (en) | Chimeric antigen receptor of targeting B cell mature antigen and application thereof | |
CN110257424B (en) | Method for editing CCR5 gene at fixed point | |
CN109609553B (en) | Method for improving NK cell targeting effect and application of CCR5 gene | |
CN108998443B (en) | Goat testis fibroblast membrane system yeast cDNA library and construction method thereof | |
CN106967663B (en) | Recombinant strain for preventing and treating crop diseases | |
CN112126645B (en) | Ring RNA (ribonucleic acid) knocking-down method and application thereof | |
CN111228292B (en) | Application of human TPT1/TCTP gene in preparation of antitumor drugs | |
CN114560948B (en) | Chimeric antigen receptor, CAR-T cell and application thereof | |
CN107383207A (en) | A kind of canine recombinant long-acting interferon α and prepare fusion protein of this long-acting interferon and preparation method thereof | |
CN118516337B (en) | Factor VII truncated body and preparation method and application thereof | |
CN114573712B (en) | Chimeric antigen receptor, CAR-T cell and application thereof | |
CN112852817B (en) | Composition for RNA editing in III-A type CRISPR-Csm system and application | |
CN107254000A (en) | A kind of fusion protein being made up of sheep albumin and sheep interferon gamma and preparation method thereof and a kind of restructuring sheep long-acting interferon γ | |
CN114478802B (en) | Chimeric antigen receptor and application thereof | |
CN114957439B (en) | Sheep PDGFD, PDGFD-encoding nucleic acid, recombinant lentivirus, host cell and application thereof | |
RU2824194C2 (en) | Methods for gene modification of hematopoietic cells | |
CN107337738A (en) | A kind of canine recombinant long-acting interferon and prepare fusion protein of this long-acting interferon and preparation method thereof | |
CN108148875B (en) | Gene editing system, expression vector, gene editing kit and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |